Delcath Systems, Inc.(NASDAQ:DCTH) shares gained 81.96% to $0.561. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers...
Delcath Systems, Inc. (NASDAQ:DCTH) shares declined 5.74% to $0.309. The company on Sept. 13 announced that the U.S. Food and Drug Administration (FDA) has issued a...